BSc (Sheffield), MSc (Oxford), MSc (Edinburgh), PhD (Crete)
I joined the Centre for Prevention of Stroke and Dementia (CPSD) as a senior statistician in April 2019, where I am currently involved in the meta-analysis of randomised controlled trials of aspirin treatment for the primary and secondary prevention of major vascular events. I am also a statistical adviser for the Research Design Service South Central, where my role involves advising researchers on the design and statistical content of proposals being prepared for submission to national funding bodies. My previous appointments were at the Centre for Statistics in Medicine (CSM) Oxford Clinical Trials Research Unit (OCTRU), 2015-2019, and the Department of Social Medicine at the University of Crete Medical School (Assistant Professor, 2008-2015). At CSM/OCTRU my role included providing input to the design, running, analysis and reporting of both early and late phase cancer clinical trials and feasibility studies. I am experienced in teaching medical statistics to students, postgraduates and health professionals. I am a facilitator on the annual RCT course run by CSM. I have supervised both undergraduate and postgraduate projects.
I am a member of the NIHR Statistics group – ophthalmology research section and the Ophthalmic Statistics Group. I am also an external reviewer for proposals and study reports submitted to the NIHR. I have served as a statistical adviser on the editorial boards of the Annals of Gastroenterology and BMC Ophthalmology. In 2011, I spent two months at the University of Minnesota as a Fulbright Research Scholar investigating the potential use of rank preserving structural failure time models in assessing the effect of smoking cessation on cardiovascular outcomes in an observational study comprising 16 cohorts followed up over a 40-year period.
DEBIOC: A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophago-gastric adenocarcinoma
Thomas A. et al, (2019), European Journal of Cancer
Quality of life in the FOXFIRE, SIRFLOX, and FOXFIRE-Global randomised trials of selective internal radiotherapy for metastatic colorectal cancer
WOLSTENHOLME J. et al, (2019), International Journal of Cancer
A Phase I dose-finding and safety study of AZD8931 with Oxaliplatin and Capecitabine chemotherapy in patients with Oesophago-gastric adenocarcinoma: the randomised expansion phase of the DEBIOC trial
Thomas A. et al, (2018)
Patients’ intention to consume prescribed and non-prescribed medicines: A study based on the theory of planned behaviour in selected European countries
Kamekis A. et al, (2018), Journal of Clinical Pharmacy and Therapeutics, 43, 26 - 35
IntReALL SR 2010: An international randomised phase III study for the treatment of standard risk childhood relapsed acute lymphoblastic leukaemia
von Stackelberg A. et al, (2017)